Gileyna significantly reduces relapses in children...

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Gileyna significantly reduces relapses in children...

Postby MSUK » Tue Sep 05, 2017 2:51 am

Phase III trial shows Gileyna significantly reduces relapses in children and adolescents with MS

A phase III Paradigms study in paediatric multiple sclerosis (MS) has met its primary end point, showing a significant reduction in the occurrence of relapses with Gileyna (also known as fingolimod) versus interferon beta-1a...Read more - http://www.ms-uk.org/phase-iii-trial-shows-gileyna-significantly-reduces-relapses-children-and-adolescents-ms
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2869
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Re: Gileyna significantly reduces relapses in children...

Postby NHE » Tue Sep 05, 2017 10:34 pm

MSUK wrote:Phase III trial shows Gileyna significantly reduces relapses in children and adolescents with MS

A phase III Paradigms study in paediatric multiple sclerosis (MS) has met its primary end point, showing a significant reduction in the occurrence of relapses with Gileyna (also known as fingolimod) versus interferon beta-1a...Read more - http://www.ms-uk.org/phase-iii-trial-shows-gileyna-significantly-reduces-relapses-children-and-adolescents-ms

But does it reduce progression of disability? That's what really counts.
User avatar
NHE
Volunteer Moderator
 
Posts: 4530
Joined: Sat Nov 20, 2004 3:00 pm


Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service


cron